328
Views
21
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide

, , , , , , , , , & show all
Pages 1342-1345 | Received 13 Apr 2014, Accepted 05 Aug 2014, Published online: 03 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tejasvini Vaid, Mukul Aggarwal, Jasmita Dass, Rishi Dhawan, Pradeep Kumar, Ganesh Kumar Viswanathan, Seema Tyagi, Tulika Seth & Manoranjan Mahapatra. (2022) Shifting gears to differentiation agents in acute promyelocytic leukemia with resource constraints—a cohort study. Acta Oncologica 61:9, pages 1050-1055.
Read now
Derek McCulloch, Christina Brown & Harry Iland. (2017) Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives. OncoTargets and Therapy 10, pages 1585-1601.
Read now

Articles from other publishers (19)

Hui Zeng, Hai‐Bo Dong, Qi‐Guo Zhang, Min Zhou, Qian Zhang, Lan‐Xin Chen, Cui‐Ying Yuan, Ru‐Ru Jiang, Jin‐Wen Liu, Jian Ou‐Yang, Jie He & Bing Chen. (2023) Additional cytogenetic abnormalities in patients with newly diagnosed acute promyelocytic leukemia predict inferior event‐free survival. Cancer Medicine.
Crossref
Shuang Fu, Mengqi Li & Hongtao Wang. (2023) BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report. Frontiers in Pharmacology 14.
Crossref
Xiaoning Wang, Ding Ding & Yalin Liu. (2022) Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report. Cancer Reports 5:11.
Crossref
Young Hoon Park, Dae-Young Kim, Yeung-Chul Mun, Eun Kyung Cho, Jae Hoon Lee, Deog-Yeon Jo, Inho Kim, Sung-Soo Yoon, Seon Yang Park, Byoungkook Kim, Soo-Mee Bang, Hawk Kim, Young Joo Min, Jae Hoo Park, Jong Jin Seo, Hyung Nam Moon, Moon Hee Lee, Chul Soo Kim, Won Sik Lee, So Young Chong, Doyeun Oh, Dae Young Zang, Kyung Hee Lee, Myung Soo Hyun, Heung Sik Kim, Sung-Hyun Kim, Hyukchan Kwon, Hyo Jin Kim, Kyung Tae Park, Sung Hwa Bae, Hun Mo Ryoo, Jung Hye Choi, Myung-Ju Ahn, Hwi-Joong Yoon, Sung-Hyun Nam, Bong-Seog Kim & Chu-Myong Seong. (2022) Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia. The Korean Journal of Internal Medicine 37:4, pages 841-850.
Crossref
V. V. Troitskaya, E. N. Parovichnikova, A. A. Semenova, Z. T. Fidarova, A. N. Sokolov, G. M. Galstyan, M. V. Spirin, E. O. Gribanova, E. P. Sysoeva, V. N. Dvirnyk, I. N. Naumova, T. N. Obukhova, O. A. Glinshchikova, G. A. Klyasova, Yu. A. Chabaeva, S. M. Kulikov & V. G. Savchenko. (2021) Risk-adapted combined therapy with arsenic trioxide and all-trans-retinoic acid for de novo acute promyelocytic leuкaemia. Russian journal of hematology and transfusiology 66:2, pages 168-191.
Crossref
Luana Lenzi, Lisa Lee-Jones, Maruf A. Mostofa, Diancarlos P. de Andrade, Raul C. Ribeiro & Bonald C. Figueiredo. (2020) Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study. Cancers 12:12, pages 3610.
Crossref
Kelly J. Norsworthy, Armen Avagyan, Steven T. Bird, Yuchen Li, Sandia Akhtar, Jiemin Liao, Michael Wernecke, Albert B. Deisseroth, Meredith Chuk, Thomas E. MaCurdy, Richard Swain, Jeffrey A. Kelman, Ann T. Farrell, R. Angelo de Claro, Richard Pazdur, Gideon Blumenthal & David J. Graham. (2020) Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis. Leukemia 34:11, pages 3082-3084.
Crossref
Zheng-Li Xu & Xiao-Jun Huang. (2020) Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era. Frontiers in Oncology 10.
Crossref
Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler & Walter Berger. (2018) Metal Drugs and the Anticancer Immune Response. Chemical Reviews 119:2, pages 1519-1624.
Crossref
Farhad Ravandi. (2018) Treatment of Acute Promyelocytic Leukemia With No or Minimal Chemotherapy: Now a Reality in Common Clinical Practice. Journal of Oncology Practice 14:11, pages 663-664.
Crossref
Yinjun Lou, Ying Lu, Zhijuan Zhu, Yafang Ma, Shanshan Suo, Yungui Wang, Dong Chen, Hongyan Tong, Wenbin Qian, Haitao Meng, Wenyuan Mai, Wenjun Yu, Weilai Xu, Lei Wang, Liping Mao, Renzhi Pei & Jie Jin. (2018) Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy. Hematological Oncology 36:3, pages 584-590.
Crossref
Peter H. Wiernik, Robert E. Gallagher & Martin S. Tallman. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 409 463 .
Matthew A. KutnyTodd A. AlonzoRobert B. GerbingYi-Cheng WangSusana C. RaimondiBetsy A. HirschCecilia H. FuSoheil MeshinchiAlan S. GamisJames H. FeusnerJohn J. GregoryJrJr. (2017) Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631. Journal of Clinical Oncology 35:26, pages 3021-3029.
Crossref
Smith Giri, Ranjan Pathak, Madan Raj Aryal, Paras Karmacharya & Vijaya Raj Bhatt. (2017) Second primary malignancy in acute promyelocytic leukemia: a Surveillance, Epidemiology and End Results database study. Future Oncology 13:17, pages 1455-1457.
Crossref
Mihaela Cîrstea, Adriana Coliță, Bogdan Ionescu, Alexandra Ghiaur, Didona Vasilescu, Camelia Dobrea, Cerasela Jardan, Mihaela Dragomir, Anca Gheorghe, Zsofia Várady & Anca Roxana Lupu. (2017) Therapy-related myelodysplastic syndrome after successful treatment of acute promyelocytic leukemia: case report and literature review. Revista Romana de Medicina de Laborator 25:2, pages 165-179.
Crossref
Yasmin Abaza, Hagop Kantarjian, Guillermo Garcia-ManeroElihu Estey, Gautam Borthakur, Elias JabbourStefan FaderlSusan O’BrienWilliam WierdaSherry PierceMark BrandtDeborah McCue, Rajyalakshmi Luthra, Keyur Patel, Steven KornblauTapan KadiaNaval DaverCourtney DiNardoNitin JainSrdan VerstovsekAlessandra FerrajoliMichael AndreeffMarina KonoplevaZeev EstrovMaria FoudrayDavid McCueJorge CortesFarhad Ravandi. (2017) Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood 129:10, pages 1275-1283.
Crossref
Eytan SteinKatharine Yen. (2017) Targeted Differentiation Therapy with Mutant IDH Inhibitors: Early Experiences and Parallels with Other Differentiation Agents. Annual Review of Cancer Biology 1:1, pages 379-401.
Crossref
Sameem Abedin & Jessica K. Altman. (2016) Acute promyelocytic leukemia: preventing early complications and late toxicities. Hematology 2016:1, pages 10-15.
Crossref
C C Coombs, M Tavakkoli & M S Tallman. (2015) Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood Cancer Journal 5:4, pages e304-e304.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.